Evidence map›Paper›PMID 21849704›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2011

Beyond phosphorylation: nuclear export in vascular remodeling.

Jane E B Reusch

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Jane E B Reusch

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
UCHSC DIABETES ENDOCRINOLOGY RESEARCH CENTERP30DK057516 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HUTTON, JOHN C · 2000 to 2010
$14.0M
Colorado Clinical and Translational Sciences InstituteKL2TR001080 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$2.6M
Colorado Clinical and Translational Science Institute (KL2)KL2RR025779 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$2.2M
Transcriptional Regulation of PDGF Receptor AlphaR01DK064741 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI REUSCH, JANE E · 2004 to 2009
$1.6M
Colorado Clinical and Translational Science Institute (KL2)KL2TR000156 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$521k
NCATS NIH HHS KL2 TR000156NCATS NIH HHS KL2 TR001080NCATS NIH HHS UL1 TR000154NCRR NIH HHS KL2 RR025779NCRR NIH HHS UL1 RR025780NHLBI NIH HHS 1P01HL014985NHLBI NIH HHS P01 HL014985NIDDK NIH HHS DK064741NIDDK NIH HHS DK 57516NIDDK NIH HHS P30 DK057516NIDDK NIH HHS R01 DK064741
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCilostazolMaleMuscle, Smooth, VascularMyocytes, Smooth MusclePhosphodiesterase 3 InhibitorsTetrazolesCilostazolPhosphodiesterase 3 InhibitorsTetrazoles

Identifiers

PMID21849704
PMCPMC3162556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.